Xilio Therapeutics Inc (XLO)
1.14
+0.06
(+5.56%)
USD |
NASDAQ |
May 17, 16:00
1.14
0.00 (0.00%)
After-Hours: 20:00
Xilio Therapeutics 1 Year Total Returns (Daily): -63.58% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -63.58% |
May 16, 2024 | -65.61% |
May 15, 2024 | -63.52% |
May 14, 2024 | -65.62% |
May 13, 2024 | -64.67% |
May 10, 2024 | -63.12% |
May 09, 2024 | -60.62% |
May 08, 2024 | -61.38% |
May 07, 2024 | -59.62% |
May 06, 2024 | -59.94% |
May 03, 2024 | -61.69% |
May 02, 2024 | -67.08% |
May 01, 2024 | -65.38% |
April 30, 2024 | -68.48% |
April 29, 2024 | -68.48% |
April 26, 2024 | -66.04% |
April 25, 2024 | -68.83% |
April 24, 2024 | -66.35% |
April 23, 2024 | -67.29% |
April 22, 2024 | -65.73% |
April 19, 2024 | -63.26% |
April 18, 2024 | -59.62% |
April 17, 2024 | -62.15% |
April 16, 2024 | -60.61% |
April 15, 2024 | -61.82% |
Date | Value |
---|---|
April 12, 2024 | -65.29% |
April 11, 2024 | -60.64% |
April 10, 2024 | -59.37% |
April 09, 2024 | -59.57% |
April 08, 2024 | -54.63% |
April 05, 2024 | -60.13% |
April 04, 2024 | -62.19% |
April 03, 2024 | -57.31% |
April 02, 2024 | -53.31% |
April 01, 2024 | -51.74% |
March 28, 2024 | -65.27% |
March 27, 2024 | -78.91% |
March 26, 2024 | -78.59% |
March 25, 2024 | -77.28% |
March 22, 2024 | -76.42% |
March 21, 2024 | -75.86% |
March 20, 2024 | -75.92% |
March 19, 2024 | -76.70% |
March 18, 2024 | -76.92% |
March 15, 2024 | -75.18% |
March 14, 2024 | -76.91% |
March 13, 2024 | -76.03% |
March 12, 2024 | -75.88% |
March 11, 2024 | -72.78% |
March 08, 2024 | -70.88% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.33%
Minimum
Nov 09 2022
42.79%
Maximum
Jun 20 2023
-47.32%
Average
-61.39%
Median
1 Year Total Returns (Daily) Benchmarks
Gilead Sciences Inc | -10.68% |
FibroGen Inc | -93.27% |
Avalo Therapeutics Inc | -98.57% |
IGM Biosciences Inc | -22.52% |
AEON Biopharma Inc | -85.22% |